Vorinostat Completed Phase 2 Trials for Adult Glioblastoma / Adult Giant Cell Glioblastoma / Adult Gliosarcoma / Recurrent Adult Brain Tumor Treatment

Indications	Status	Purpose	Phase
DBCOND0028734 (Adult Glioblastoma) DBCOND0028733 (Adult Giant Cell Glioblastoma) DBCOND0028735 (Adult Gliosarcoma) DBCOND0029255 (Recurrent Adult Brain Tumor)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00238303	Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme	Vorinostat (DB02546)
NCT00641706	Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme	Vorinostat (DB02546) Bortezomib (DB00188)